HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The cellular and molecular progression of mitochondrial dysfunction induced by 2,4-dinitrophenol in developing zebrafish embryos.

Abstract
The etiology of mitochondrial disease is poorly understood. Furthermore, treatment options are limited, and diagnostic methods often lack the sensitivity to detect disease in its early stages. Disrupted oxidative phosphorylation (OXPHOS) that inhibits ATP production is a common phenotype of mitochondrial disorders that can be induced in zebrafish by exposure to 2,4-dinitrophenol (DNP), a FDA-banned weight-loss agent and EPA-regulated environmental toxicant, traditionally used in research labs as an uncoupler of OXPHOS. Despite the DNP-induced OXPHOS inhibition we observed using in vivo respirometry, the development of the DNP-treated and control zebrafish were largely similar during the first half of embryogenesis. During this period, DNP-treated embryos induced gene expression of mitochondrial and nuclear genes that stimulated the production of new mitochondria and increased glycolysis to yield normal levels of ATP. DNP-treated embryos were incapable of sustaining this mitochondrial biogenic response past mid-embryogenesis, as shown by significantly lowered ATP production and ATP levels, decreased gene expression, and the onset of developmental defects. Examining neural tissues commonly affected by mitochondrial disease, we found that DNP exposure also inhibited motor neuron axon arbor outgrowth and the proper formation of the retina. We observed and quantified the molecular and physiological progression of mitochondrial dysfunction during development with this new model of OXPHOS dysfunction, which has great potential for use in diagnostics and therapies for mitochondrial disease.
AuthorsJennifer E Bestman, Krista D Stackley, Jennifer J Rahn, Tucker J Williamson, Sherine S L Chan
JournalDifferentiation; research in biological diversity (Differentiation) 2015 Mar-Apr Vol. 89 Issue 3-4 Pg. 51-69 ISSN: 1432-0436 [Electronic] England
PMID25771346 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Adenosine Triphosphate
  • 2,4-Dinitrophenol
Topics
  • 2,4-Dinitrophenol (toxicity)
  • Adenosine Triphosphate (biosynthesis)
  • Animals
  • Embryonic Development (genetics)
  • Energy Metabolism (genetics)
  • Gene Expression Regulation, Developmental (drug effects)
  • Humans
  • Mitochondria (genetics, metabolism, pathology)
  • Mitochondrial Diseases (chemically induced, genetics, metabolism, pathology)
  • Motor Neurons (metabolism, pathology)
  • Oxidative Phosphorylation (drug effects)
  • Retina (metabolism, pathology)
  • Zebrafish

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: